Form 4 for AMGN Amgen
Accepted 2024-07-31 00:00:00 ET · period of report 2024-07-31 · accession 0001127602-24-021277 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-07-31 | 2024-07-31 | AMGN | Grygiel Nancy A. | SVP, CCO | F - Tax | $333.28 | -1,565 | 8,771 | -15% | -$521.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-07-31 | F | D | 1,565 | $333.28 | 8,771 | D | — | — | (F2) These shares include 86 Dividend Equivalents (DEs) granted pursuant to the Company's Equity Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. (F1) These shares include the following Restricted Stock Units (RSUs) granted under the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan (the Equity Plan): 199 RSUs which will vest on 4/30/2025; 435 RSUs which will vest in installments of 214 on 5/2/2025, and one installment of 221 on 5/2/2026; 635 RSUs which will vest in installments of 209 on 5/2/2025, 210 on 5/2/2026 and 216 on 5/2/2027; and 499 RSUs which will vest in installments of 164 on 5/7/2026, 165 on 5/7/2027, and 170 on 5/7/2028. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. |